Nymox Pharmaceutical Corp (NASDAQ:NYMX)

Data as of Apr 15
 -0.18 / -3.29%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Nymox Pharmaceutical Corp. is a biopharmaceutical company. The company, which is engaged in the research and development of therapeutics with a particular emphasis on products targeted for the unmet needs of the aging population. It offers NicAlert and TobacAlert tests for measuring tobacco product exposure and AlzheimAlert, a test to aid in the diagnosis of Alzheimer's disease. Nymox Pharmaceutical was founded by Paul Averback on May 30, 1995 and is headquartered in Saint-Laurent, Canada.

Contact Information

Nymox Pharmaceutical Corp.
9900, boulevard Cavendish
Saint-Laurent Quebec H4M 2V2
P:(800) 936-9669
Investor Relations:



Other institutional1.78%
Mutual fund holders1.44%
Individual stakeholders--

Top Executives

Paul AverbackChairman, President & Chief Executive Officer
André MonetteChief Financial Officer
Jack GemmellDirector & Chief Information Officer
Roy M. WolvinSecretary & Treasurer
Brian DoyleManager-Global Sales

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.